PMID- 10653823 OWN - NLM STAT- MEDLINE DCOM- 20000218 LR - 20190623 IS - 1524-4539 (Electronic) IS - 0009-7322 (Linking) VI - 101 IP - 4 DP - 2000 Feb 1 TI - Laminar shear stress upregulates the complement-inhibitory protein clusterin : a novel potent defense mechanism against complement-induced endothelial cell activation. PG - 352-5 AB - BACKGROUND: The complement system is implicated in the pathogenesis of atherosclerosis. Complement has been shown to activate endothelial cells (ECs) by inducing a proinflammatory response. Physiological levels of shear stress exert potent antiatherosclerotic effects. Therefore, we investigated whether shear stress antagonizes the effects of complement on ECs. METHODS AND RESULTS: Incubation of ECs with nonlytic concentrations of complement serum (CS: 0.2 U/mL for 6 hours) resulted in an upregulation of interleukin-8 (IL-8) (165+/-12%) and monocyte chemoattractant protein-1 (MCP-1) mRNA expression (267+/-34%). Preexposure of ECs for 18 hours with laminar shear stress (15 dyne/cm(2)) abrogated CS-induced IL-8 release to 106+/-10% (P<0.001) and reduced CS-induced MCP-1 expression (170+/-31%; P<0.05). To examine the mechanism of the protective effect of shear stress, expression of the complement-inhibitory protein clusterin was analyzed under shear exposure. Shear stress increased clusterin mRNA (225+/-76%, 6 hours) and protein expression (164+/-22%, 18 hours). Specific inhibition of clusterin by transfection with antisense oligonucleotides reversed the protective effect of shear stress on CS-induced MCP-1 and IL-8 upregulation (P<0.05 versus sense-transfected cells). Moreover, clusterin overexpression inhibited CS-induced EC activation. CONCLUSIONS: Shear stress abrogates the complement-induced proinflammatory response of ECs by upregulation of the complement-inhibitory protein clusterin. Upregulation of clusterin may contribute to the potent antiatherosclerotic effects of shear stress by preventing endothelial activation through the complement cascade. FAU - Urbich, C AU - Urbich C AD - Molecular Cardiology, Department of Internal Medicine IV, University of Frankfurt, Germany. FAU - Fritzenwanger, M AU - Fritzenwanger M FAU - Zeiher, A M AU - Zeiher AM FAU - Dimmeler, S AU - Dimmeler S LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - Circulation JT - Circulation JID - 0147763 RN - 0 (CLU protein, human) RN - 0 (Chemokine CCL2) RN - 0 (Clusterin) RN - 0 (Complement Inactivator Proteins) RN - 0 (Glycoproteins) RN - 0 (Interleukin-8) RN - 0 (Molecular Chaperones) RN - 0 (RNA, Messenger) RN - 0 (Recombinant Proteins) RN - 9007-36-7 (Complement System Proteins) SB - IM MH - Cells, Cultured MH - Chemokine CCL2/genetics MH - Clusterin MH - Complement Inactivator Proteins/*biosynthesis/genetics MH - Complement System Proteins/*physiology MH - Endothelium, Vascular/*physiology MH - Gene Expression Regulation/immunology MH - Glycoproteins/*biosynthesis/genetics MH - Humans MH - Interleukin-8/genetics MH - *Molecular Chaperones MH - RNA, Messenger/genetics MH - Recombinant Proteins/biosynthesis MH - Stress, Mechanical MH - *Transcription, Genetic MH - Transfection MH - Umbilical Veins EDAT- 2000/02/02 00:00 MHDA- 2000/02/26 00:00 CRDT- 2000/02/02 00:00 PHST- 2000/02/02 00:00 [pubmed] PHST- 2000/02/26 00:00 [medline] PHST- 2000/02/02 00:00 [entrez] AID - 10.1161/01.cir.101.4.352 [doi] PST - ppublish SO - Circulation. 2000 Feb 1;101(4):352-5. doi: 10.1161/01.cir.101.4.352.